ALZHEIMERS DISEASE
Clinical trials for ALZHEIMERS DISEASE explained in plain language.
Never miss a new study
Get alerted when new ALZHEIMERS DISEASE trials appear
Sign up with your email to follow new studies for ALZHEIMERS DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could a new drug delay Alzheimer's in people with genetic risk?
Disease control OngoingThis study tests an investigational drug (E2814) combined with lecanemab in people who carry a gene mutation that causes Alzheimer's. The goal is to see if the drug can slow brain changes and delay memory loss. About 197 adults aged 18-80 with mild symptoms or no symptoms are par…
Matched conditions: ALZHEIMERS DISEASE
Phase: PHASE2, PHASE3 • Sponsor: Washington University School of Medicine • Aim: Disease control
Last updated Apr 30, 2026 15:51 UTC
-
Gum treatment may fight Alzheimer's: new trial launches
Disease control ENROLLING_BY_INVITATIONThis study explores whether treating advanced gum disease can slow down Alzheimer's disease. Researchers think that gum infections cause body-wide inflammation, which may worsen Alzheimer's. 26 people with both conditions will receive gum treatment and be monitored for 2 years wi…
Matched conditions: ALZHEIMERS DISEASE
Phase: NA • Sponsor: Centre Hospitalier Universitaire de Liege • Aim: Disease control
Last updated Apr 30, 2026 15:50 UTC
-
Blood test aims to cut Alzheimer's diagnosis time
Diagnosis TerminatedThis study looked at whether using a blood test (PrecivityAD2) could help doctors diagnose Alzheimer's disease or other memory problems more quickly. It planned to involve veterans and other adults aged 50+ with mild memory issues. The study was withdrawn before enrolling anyone,…
Matched conditions: ALZHEIMERS DISEASE
Phase: NA • Sponsor: C2N Diagnostics • Aim: Diagnosis
Last updated May 01, 2026 15:57 UTC